triazoles has been researched along with simvastatin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samuels, S; Thompson, M | 1 |
| Monaghan, MS; Skrabal, MZ; Stading, JA | 1 |
| Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX | 1 |
| Kao, DP; Kohrt, HE; Kugler, J | 1 |
| Bergman, AJ; Cote, J; Davies, MJ; De Smet, M; Herman, GA; Keymeulen, B; Laethem, T; Maes, A; Mathijs, Z; Roadcap, BA; Sun, L; Valesky, RJ; Wagner, JA; Yang, A; Zhao, JJ | 1 |
| Boucher, BJ | 1 |
| Bao, T; Blackford, AL; Stearns, V | 1 |
| Krishna, G; Ma, L; Martinho, M; Moton, A; O'Mara, E; Prasad, P | 1 |
| Burugula, L; Kandhagatla, R; Lodagala, DS; Makula, A; Mullangi, R; Pilli, NR | 1 |
| Anderson, MS; Cerra, M; Li, SX; Luo, WL; Matthews, C; O'Neill, EA; Stoch, SA; Wagner, JA | 1 |
| Anderson, MS; Engel, SS; Hanson, ME; Musliner, T; Steinberg, H | 1 |
| Kabbara, WK; Ramadan, WH | 1 |
2 review(s) available for triazoles and simvastatin
| Article | Year |
|---|---|
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.
Topics: Biomarkers; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Lipids; Pyrazines; Simvastatin; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2013 |
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypoglycemia; Polypharmacy; Pyrazines; Risk Factors; Simvastatin; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Gain | 2015 |
3 trial(s) available for triazoles and simvastatin
| Article | Year |
|---|---|
Effect of sitagliptin on the pharmacokinetics of simvastatin.
Topics: Adult; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Pyrazines; Simvastatin; Sitagliptin Phosphate; Time Factors; Triazoles | 2009 |
Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Male; Midazolam; Middle Aged; Simvastatin; Triazoles; Young Adult | 2012 |
The effects of simvastatin on the pharmacokinectics of sitagliptin.
Topics: Adult; Area Under Curve; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrazines; Simvastatin; Sitagliptin Phosphate; Triazoles; Young Adult | 2012 |
8 other study(ies) available for triazoles and simvastatin
| Article | Year |
|---|---|
Rhabdomyolysis with simvastatin and nefazodone.
Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles | 2002 |
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles | 2003 |
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles | 2008 |
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use.
Topics: Acute Kidney Injury; Aged; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrazines; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles | 2008 |
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?
Topics: Amiodarone; Contraindications; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pyrazines; Renal Insufficiency; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles; United Kingdom; United States | 2009 |
Sitagliptin and simvastatin (juvisync).
Topics: Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Costs; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrazines; Simvastatin; Sitagliptin Phosphate; Triazoles | 2011 |
Effect of simvastatin on the pharmacokinetics of anastrozole.
Topics: Aged; Anastrozole; Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Estradiol; Estrone; Female; Humans; Middle Aged; Nitriles; Pilot Projects; Simvastatin; Triazoles | 2012 |
Simultaneous determination of sitagliptin and simvastatin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
Topics: Administration, Oral; Chromatography, Liquid; Dipeptidyl-Peptidase IV Inhibitors; Drug Stability; Humans; Least-Squares Analysis; Liquid-Liquid Extraction; Male; Pyrazines; Reproducibility of Results; Sensitivity and Specificity; Simvastatin; Sitagliptin Phosphate; Tandem Mass Spectrometry; Triazoles | 2013 |